Cotización MoonLake Immunotherapeut... - MLTX

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Último Precio

48.83

Postura de Compra

38.00

Postura de Venta

66.00

Volume Operado de la Acción

412,764

48.30 Rango del Día 52.24

37.345 Rango de 52 semanas 64.98

Capitalización de Mercado [m]

3.12B

Precio Anterior

52.50

Precio de Apertura

51.98

Hora

48.44

Última hora de negociación

Volumen financiero

US$ 20,409,740

Precio Promedio Ponderado

49.4465

Volumen promedio (3 m)

310,046

Acciones en circulación

63,905,198

Rendimiento del Dividendo

Ratio Precio/Utilidad

-70.76

Beneficio por acción (BPA)

-0.69

turnover

Beneficio neto

-44.08M

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

Sector

Blank Checks

Industria

Pharmaceutical Preparations

Sitio web

moonlaketx.com

Sede

Grand Cayman, Cym

Fundado

2020

MoonLake Immunotherapeutics is listed in the Blank Checks sector of the NASDAQ with ticker MLTX. The last closing price for MoonLake Immunotherapeut... was US$52.50. Over the last year, MoonLake Immunotherapeut... shares have traded in a share price range of US$ 37.345 to US$ 64.98.

MoonLake Immunotherapeut... currently has 63,905,198 shares in issue. The market capitalisation of MoonLake Immunotherapeut... is US$3.36 billion. MoonLake Immunotherapeut... has a price to earnings ratio (PE ratio) of -70.76.

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis Two trials for active psoriatic arthritis (PsA) with one focusing...

MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11

MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11 Initiated Phase 3 VELA program of the Nanobody® sonelokimab in...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-1.63	-3.23028141102	50.46	54.81	48.81	194846	52.45412424	CS
4	0.75	1.55990016639	48.08	54.81	45.24	222357	48.92208819	CS
12	0.04	0.0819840131174	48.79	56	44.71	310046	50.46322464	CS
26	7.37	17.7761698022	41.46	56	37.55	327719	46.30796714	CS
52	11.33	30.2133333333	37.5	64.98	37.345	402700	49.03828185	CS
156	36.46	294.745351657	12.37	64.98	4.25	349925	42.79406019	CS
260	36.46	294.745351657	12.37	64.98	4.25	349925	42.79406019	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.17B
CYCNCyclerion Therapeutics Inc	US$ 2.5306 (42.97%)	11.99M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	165.69M
PULMPulmatrix Inc	US$ 6.5586 (39.54%)	5.37M
ZTEKZentek Ltd	US$ 1.2574 (29.96%)	309.67k
TFFPTFF Pharmaceuticals Inc	US$ 0.376101 (-76.49%)	9.35M
EYENEyenovia Inc	US$ 0.10185 (-70.05%)	52.8M
CTXRCitius Pharmaceuticals Inc	US$ 0.1974 (-39.89%)	11.26M
VVPRVivoPower International PLC	US$ 0.8151 (-39.62%)	2.34M
IPWiPower Inc	US$ 0.7302 (-39.15%)	1.15M
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.17B
ELABElevai Labs Inc	US$ 0.0211 (-19.47%)	380.03M
NVDANVIDIA Corporation	US$ 141.98 (-3.26%)	253.02M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	165.69M
STISolidion Technology Inc	US$ 0.44 (25.71%)	140.02M